By Susanna Moon
Chicago, Aug. 27 – JPMorgan Chase & Co. priced $18.17 million of autocallable contingent interest notes due Sept. 10, 2015 linked to Valeant Pharmaceuticals International, Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 19.8% if Valeant shares close at or above the barrier level, 75% of the initial share price, on the review date for that quarter.
The notes will be called at par plus the contingent coupon if Valeant shares close at or above the initial share price on any quarterly review date other than the final review date.
If the stock finishes at or above the barrier level, the payout at maturity will be par plus the contingent coupon.
Otherwise, investors will be fully exposed to any losses.
J.P. Morgan Securities LLC is the agent.
Issuer: | JPMorgan Chase & Co.
|
Issue: | Autocallable contingent interest notes
|
Underlying stock: | Valeant Pharmaceuticals International, Inc. (Symbol: VRX)
|
Amount: | $18,167,000
|
Maturity: | Sept. 10, 2015
|
Coupon: | 19.8% annualized for each quarter that Valeant stock closes at or above coupon barrier level on review date for that quarter
|
Price: | Par
|
Payout at maturity: | Par plus contingent coupon unless the stock falls below trigger level, in which case exposure to any losses
|
Call: | At par plus contingent coupon if Valeant shares close at or above initial share price on any quarterly review date other than final review date
|
Initial share price: | $117.26
|
Barrier level: | $87.945, 75% of initial share price
|
Pricing date: | Aug. 22
|
Settlement date: | Aug. 27
|
Agent: | J.P. Morgan Securities LLC
|
Fees: | 1%
|
Cusip: | 48127DXT0
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.